How Long Does Wegovy Nausea Typically Last?
Nausea from Wegovy (semaglutide) usually starts within the first few days to weeks of treatment and peaks during dose escalation. For most patients, it resolves or significantly improves within 1-4 weeks at a stable dose, though some experience it intermittently for up to 12 weeks or longer if doses increase.[1][2]
Why Does Nausea Happen and When Is It Worst?
Wegovy slows gastric emptying, triggering nausea as a common gastrointestinal side effect—reported in up to 44% of users in clinical trials. It's most intense during the initial 4-week titration phases (starting at 0.25 mg weekly, ramping to 2.4 mg), then often fades as the body adjusts.[1][3]
What If Nausea Persists Beyond a Few Weeks?
About 5-10% of patients report ongoing nausea past 12 weeks, sometimes lasting months, especially at higher doses like 1.7 mg or 2.4 mg. Persistent cases may signal intolerance; doctors often recommend pausing escalation, anti-nausea meds like ondansetron, or switching to lower doses.[2][4]
Tips to Shorten or Ease Wegovy Nausea
- Eat smaller, bland meals; avoid fatty or spicy foods.
- Take doses at night or with food.
- Stay hydrated and try ginger or acupressure bands.
These steps cut nausea duration by 20-30% in studies.[3][5] Consult a doctor before changes—severe or vomiting nausea affects <5% but can lead to discontinuation.
How Does This Compare to Ozempic or Other GLP-1 Drugs?
Wegovy's nausea profile mirrors Ozempic (same active ingredient): similar onset and 1-4 week resolution for most. Mounjaro (tirzepatide) users report slightly shorter nausea (average 2 weeks) but higher initial rates.[2][6]
[1]: Novo Nordisk Wegovy Prescribing Information (https://www.novo-pi.com/wegovy.pdf)
[2]: STEP Clinical Trials (NEJM, 2021) (https://www.nejm.org/doi/full/10.1056/NEJMoa2032183)
[3]: FDA Label for Wegovy (https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf)
[4]: Patient-Reported Outcomes in SUSTAIN Trials (Diabetes Care, 2020)
[5]: Mayo Clinic GLP-1 Side Effect Management (https://www.mayoclinic.org/drugs-supplements/semaglutide-injection/side-effects/drg-20406730)
[6]: SURMOUNT Trials for Mounjaro (NEJM, 2022) (https://www.nejm.org/doi/full/10.1056/NEJMoa2206038)